Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Terran Biosciences Inc.
Headquarters: New York, NY, United States of America
Website: https://terranbiosciences.com/...
Year Founded: 2017
Status: Private
BioCentury | Sep 27, 2024
Market Access
BMS’s new schizophrenia drug has big potential, but won’t be an overnight success
Market access and indication expansion will gate Cobenfy’s ability to help fill the pharma’s major revenue holes
BioCentury | Jan 24, 2024
Data Byte
Schizophrenia pipeline: two PDUFA dates and a dozen readouts in 2024
A look ahead to the schizophrenia milestones coming this year, and the mechanisms behind them
BioCentury | Apr 21, 2022
Deals
April 21 Quick Takes: Reify’s big round to support clinical trial diversity
Plus Terran gains rights to two late-stage candidates from Sanofi, and updates from Ampio, Nephris, Jacobus and more
Items per page:
1 - 3 of 3